Systematic Review
. 2012 Jun; 134(2):459-78.
doi: 10.1007/s10549-012-2114-5.

Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review

Caitlin C Murphy 1 L Kay Bartholomew  Melissa Y Carpentier  Shirley M Bluethmann  Sally W Vernon  
  • PMID: 22689091
  •     79 References
  •     194 citations


Adjuvant hormonal therapy significantly improves long-term survival of breast cancer patients with hormone receptor-positive disease. Despite the proven clinical efficacy of tamoxifen and aromatase inhibitors, many breast cancer survivors either fail to take the correct dosage at the prescribed frequency (adherence) or discontinue therapy (persistence). This systematic review aims to: (1) determine the prevalence of adherence and persistence to adjuvant hormonal therapy among breast cancer survivors in clinical practice, and (2) identify correlates of adherence and persistence. We searched Medline, PubMed, PsycINFO, and CINAHL for studies that measured rates and/or correlates of adherence and/or persistence to adjuvant hormonal therapy. Studies were reviewed in a multi-step process: (1) the lead author screened titles and abstracts of all potentially eligible studies; (2) each coauthor reviewed a random 5 % sample of abstracts; and (3) two sets of coauthors each reviewed half of all "maybe" abstracts. Any disagreements were discussed until consensus was reached. Twenty-nine studies met inclusion criteria. Prevalence of adherence ranged from 41 to 72 % and discontinuation (i.e., nonpersistence) ranged from 31 to 73 %, measured at the end of 5 years of treatment. Extremes of age (older or younger), increasing out-of-pocket costs, follow-up care with a general practitioner (vs. oncologist), higher CYP2D6 activity, switching from one form of therapy to another, and treatment side effects were negatively associated with adherence and/or persistence. Taking more medications at baseline, referral to an oncologist, and earlier year at diagnosis were positively associated with adherence and/or persistence. Adherence and persistence to adjuvant hormonal therapy among breast cancer survivors is suboptimal. Many of the correlates of adherence and persistence studied to date are not modifiable. Our review reveals a critical need for further research on modifiable factors associated with adherence to adjuvant hormonal therapy, and the development of behavioral interventions to improve adherence in this population.

Initial treatment and changes in adjuvant endocrine therapy for early stage breast cancer.
Lee S Schwartzberg, Patrick Cobb, +5 authors, Edward J Stepanski.
Breast, 2009 Apr 04; 18(2). PMID: 19342237
Use of tamoxifen and aromatase inhibitors in a large population-based cohort of women with breast cancer.
L Huiart, S Dell'Aniello, S Suissa.
Br J Cancer, 2011 Apr 28; 104(10). PMID: 21522148    Free PMC article.
Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review.
Anne Nedrow, Jill Miller, +3 authors, Heidi D Nelson.
Arch Intern Med, 2006 Jul 26; 166(14). PMID: 16864755
Systematic Review.
Age-specific nonpersistence of endocrine therapy in postmenopausal patients diagnosed with hormone receptor-positive breast cancer: a TEAM study analysis.
Willemien van de Water, Esther Bastiaannet, +8 authors, Cornelis J H van de Velde.
Oncologist, 2012 Jan 03; 17(1). PMID: 22210087    Free PMC article.
Taking CHARGE: A self-management program for women following breast cancer treatment.
Bernadine Cimprich, Nancy K Janz, +3 authors, Charles W Given.
Psychooncology, 2005 Jan 15; 14(9). PMID: 15651055
Improving compliance and persistence to adjuvant tamoxifen and aromatase inhibitor therapy.
Peyman Hadji.
Crit Rev Oncol Hematol, 2009 Mar 21; 73(2). PMID: 19299162
Differences between primary care physicians' and oncologists' knowledge, attitudes and practices regarding the care of cancer survivors.
Arnold L Potosky, Paul K J Han, +7 authors, Michael Stefanek.
J Gen Intern Med, 2011 Jul 26; 26(12). PMID: 21785923    Free PMC article.
Highly Cited.
Drug switch because of treatment-related adverse side effects in endocrine adjuvant breast cancer therapy: how often and how often does it work?
Uwe Güth, Mary Elizabeth Myrick, +2 authors, Seraina Margaretha Schmid.
Breast Cancer Res Treat, 2011 Jul 14; 129(3). PMID: 21750963
Patient centered experiences in breast cancer: predicting long-term adherence to tamoxifen use.
Katherine L Kahn, Eric C Schneider, +2 authors, Arnold M Epstein.
Med Care, 2007 Apr 21; 45(5). PMID: 17446829
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial.
Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trialists' Group, John F Forbes, +4 authors, Michael Baum.
Lancet Oncol, 2007 Dec 18; 9(1). PMID: 18083636
Highly Cited.
The Impact of Breast Care Nurses on Patients' Satisfaction, Understanding of the Disease, and Adherence to Adjuvant Endocrine Therapy.
Ute-Susann Albert, Cosima Zemlin, +5 authors, Matthias Kalder.
Breast Care (Basel), 2011 Jul 23; 6(3). PMID: 21779228    Free PMC article.
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, +2 authors, PRISMA Group.
J Clin Epidemiol, 2009 Jul 28; 62(10). PMID: 19631508
Highly Cited.
Managing the toxicities of the aromatase inhibitors.
Joanne E Mortimer.
Curr Opin Obstet Gynecol, 2009 Dec 19; 22(1). PMID: 20019610
Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy.
David Cella, Lesley J Fallowfield.
Breast Cancer Res Treat, 2007 Sep 19; 107(2). PMID: 17876703
Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer.
Jennifer C Livaudais, Dawn L Hershman, +7 authors, Gloria D Coronado.
Breast Cancer Res Treat, 2011 Sep 17; 131(2). PMID: 21922245    Free PMC article.
Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer.
C McCowan, J Shearer, +4 authors, T P Fahey.
Br J Cancer, 2008 Nov 06; 99(11). PMID: 18985046    Free PMC article.
Highly Cited.
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG), C Davies, +11 authors, R Peto.
Lancet, 2011 Aug 02; 378(9793). PMID: 21802721    Free PMC article.
Highly Cited.
Tolerability of hormone therapies for breast cancer: how informative are documented symptom profiles in medical notes for 'well-tolerated' treatments?
D Fellowes, L J Fallowfield, C M Saunders, J Houghton.
Breast Cancer Res Treat, 2001 May 23; 66(1). PMID: 11368413
Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor--positive breast cancer.
Aliza K Fink, Jerry Gurwitz, +2 authors, Rebecca A Silliman.
J Clin Oncol, 2004 Aug 18; 22(16). PMID: 15310774
Side effects of aromatase inhibitors versus tamoxifen: the patients' perspective.
Jennifer R Garreau, Tammy Delamelena, +2 authors, Nathalie Johnson.
Am J Surg, 2006 Sep 19; 192(4). PMID: 16978958
Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
Lancet, 1998 May 30; 351(9114). PMID: 9605801
Highly Cited.
Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial.
Patricia A Ganz, Lorna Kwan, +5 authors, Thomas R Belin.
J Natl Cancer Inst, 2004 Mar 05; 96(5). PMID: 14996859
Highly Cited.
Adjuvant endocrine therapy with tamoxifen in young women with breast cancer: determinants of interruptions vary over time.
C Cluze, D Rey, +5 authors, R Giorgi.
Ann Oncol, 2011 Jul 27; 23(4). PMID: 21788360
Management of menopausal symptoms in patients with breast cancer: an evidence-based approach.
Martha Hickey, Christobel M Saunders, Bronwyn G A Stuckey.
Lancet Oncol, 2005 Sep 01; 6(9). PMID: 16129369
Compliance to adjuvant therapy in breast cancer patients.
C Dittmer, K Roeder, +3 authors, D Fischer.
Eur J Gynaecol Oncol, 2011 Jul 30; 32(3). PMID: 21797116
Adjuvant tamoxifen: predictors of use, side effects, and discontinuation in older women.
S Demissie, R A Silliman, T L Lash.
J Clin Oncol, 2001 Feb 24; 19(2). PMID: 11208822
Improving adherence to endocrine therapies: the role of advanced practice nurses.
Anne Kelly, Christine R Agius.
Oncology (Williston Park), 2007 Dec 25; 20(10 Suppl Nurse Ed). PMID: 18153980
Predicting adherence to tamoxifen for breast cancer adjuvant therapy and prevention.
Jennifer H Lin, Shumin M Zhang, JoAnn E Manson.
Cancer Prev Res (Phila), 2011 Sep 07; 4(9). PMID: 21893499
Adherence to adjuvant therapy in post-menopausal breast cancer patients: a review.
M Banning.
Eur J Cancer Care (Engl), 2011 Oct 19; 21(1). PMID: 22004071
Adherence to long-term adjuvant hormonal therapy for breast cancer.
Carolyn Gotay, Julia Dunn.
Expert Rev Pharmacoecon Outcomes Res, 2011 Nov 22; 11(6). PMID: 22098287
Adherence to tamoxifen over the five-year course.
Timothy L Lash, Matthew P Fox, +2 authors, Rebecca A Silliman.
Breast Cancer Res Treat, 2006 Mar 17; 99(2). PMID: 16541307
Five-year patterns of adjuvant hormonal therapy use, persistence, and adherence among insured women with early-stage breast cancer.
Larissa Nekhlyudov, Lingling Li, Dennis Ross-Degnan, Anita K Wagner.
Breast Cancer Res Treat, 2011 Aug 16; 130(2). PMID: 21842245
Menopausal-type symptoms among breast cancer patients on aromatase inhibitor therapy.
L Gallicchio, R MacDonald, +2 authors, K J Helzlsouer.
Climacteric, 2011 Dec 24; 15(4). PMID: 22191462
Patient adherence and persistence with oral anticancer treatment.
Kathryn Ruddy, Erica Mayer, Ann Partridge.
CA Cancer J Clin, 2009 Jan 17; 59(1). PMID: 19147869
Highly Cited. Review.
Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer.
Alfred I Neugut, Milayna Subar, +5 authors, Dawn L Hershman.
J Clin Oncol, 2011 May 25; 29(18). PMID: 21606426    Free PMC article.
Highly Cited.
Adherence to oral endocrine treatments in women with breast cancer: can it be improved?
Sheila A Doggrell.
Breast Cancer Res Treat, 2011 May 20; 129(2). PMID: 21594663
Comprehensive CYP2D6 genotype and adherence affect outcome in breast cancer patients treated with tamoxifen monotherapy.
Alastair M Thompson, Andrea Johnson, +15 authors, William G Newman.
Breast Cancer Res Treat, 2010 Sep 03; 125(1). PMID: 20809362
Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based study.
Annette Wigertz, Johan Ahlgren, +5 authors, Mats Lambe.
Breast Cancer Res Treat, 2012 Jan 31; 133(1). PMID: 22286315
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.
A Howell, J Cuzick, +8 authors, ATAC Trialists' Group.
Lancet, 2005 Jan 11; 365(9453). PMID: 15639680
Highly Cited.
Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer.
Dawn L Hershman, Theresa Shao, +6 authors, Alfred I Neugut.
Breast Cancer Res Treat, 2010 Aug 31; 126(2). PMID: 20803066    Free PMC article.
Highly Cited.
Benefits from an uncertainty management intervention for African-American and Caucasian older long-term breast cancer survivors.
Merle H Mishel, Barbara B Germino, +5 authors, Margaret Clayton.
Psychooncology, 2005 Feb 16; 14(11). PMID: 15712339
Adjuvant hormonal therapy use among insured, low-income women with breast cancer.
Gretchen Kimmick, Roger Anderson, +3 authors, Rajesh Balkrishnan.
J Clin Oncol, 2009 May 20; 27(21). PMID: 19451445    Free PMC article.
Half of breast cancer patients discontinue tamoxifen and any endocrine treatment before the end of the recommended treatment period of 5 years: a population-based analysis.
Myrthe P P van Herk-Sukel, Lonneke V van de Poll-Franse, +3 authors, Ron M C Herings.
Breast Cancer Res Treat, 2010 Jan 09; 122(3). PMID: 20058066
Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis.
Heidi D Nelson, Kimberly K Vesco, +6 authors, Linda Humphrey.
JAMA, 2006 May 04; 295(17). PMID: 16670414
Highly Cited. Systematic Review.
Endocrine therapy use among elderly hormone receptor-positive breast cancer patients enrolled in Medicare Part D.
Gerald F Riley, Joan L Warren, Linda C Harlan, Steven A Blackwell.
Medicare Medicaid Res Rev, 2012 Feb 22; 1(4). PMID: 22340780    Free PMC article.
Women's perceptions and experience of adjuvant tamoxifen therapy account for their adherence: breast cancer patients' point of view.
Isabelle Pellegrini, Aline Sarradon-Eck, +5 authors, Claire Julian-Reynier.
Psychooncology, 2009 Jun 10; 19(5). PMID: 19507263
Noncompliance with adjuvant radiation, chemotherapy, or hormonal therapy in breast cancer patients.
Aye Moe Thu Ma, Julie Barone, +5 authors, Paul Ian Tartter.
Am J Surg, 2008 Sep 24; 196(4). PMID: 18809051
Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors.
N Lynn Henry, Jon T Giles, +13 authors, Daniel J Clauw.
Breast Cancer Res Treat, 2007 Oct 09; 111(2). PMID: 17922185    Free PMC article.
Aromatase inhibitor-associated arthralgia and/ or bone pain: frequency and characterization in non-clinical trial patients.
Cary A Presant, Linda Bosserman, +6 authors, Frank Howard.
Clin Breast Cancer, 2007 Nov 21; 7(10). PMID: 18021478
Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients.
Dawn L Hershman, Lawrence H Kushi, +7 authors, Alfred I Neugut.
J Clin Oncol, 2010 Jun 30; 28(27). PMID: 20585090    Free PMC article.
Highly Cited.
Adherence to oral endocrine therapy for breast cancer: a nursing perspective.
Christine Miaskowski, Lillie Shockney, Rowan T Chlebowski.
Clin J Oncol Nurs, 2008 Apr 09; 12(2). PMID: 18390458
Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patients.
J M Rae, M J Sikora, +11 authors, COBRA investigators.
Pharmacogenomics J, 2009 May 08; 9(4). PMID: 19421167    Free PMC article.
Adherence to adjuvant hormonal therapy and its relationship to breast cancer recurrence and survival among low-income women.
Kathryn E Weaver, Fabian Camacho, +2 authors, Gretchen Kimmick.
Am J Clin Oncol, 2012 Feb 09; 36(2). PMID: 22314001    Free PMC article.
Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial.
P A Ganz, G A Greendale, +3 authors, T R Belin.
J Natl Cancer Inst, 2000 Jul 06; 92(13). PMID: 10880548
Patient adherence to aromatase inhibitor treatment in the adjuvant setting.
S Verma, Y Madarnas, +2 authors, J Bajcar.
Curr Oncol, 2011 Jun 24; 18 Suppl 1. PMID: 21698059    Free PMC article.
Non-initiation of adjuvant hormonal therapy in women with hormone receptor-positive breast cancer: The Breast Cancer Quality of Care Study (BQUAL).
Alfred I Neugut, Grace Clarke Hillyer, +10 authors, Dawn L Hershman.
Breast Cancer Res Treat, 2012 Apr 25; 134(1). PMID: 22527111    Free PMC article.
Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer.
Ann H Partridge, Andrea LaFountain, +3 authors, Aviva Asnis-Alibozek.
J Clin Oncol, 2008 Jan 09; 26(4). PMID: 18180462
Highly Cited.
Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancer.
N Lynn Henry, Faouzi Azzouz, +10 authors, Anna Maria Storniolo.
J Clin Oncol, 2012 Feb 15; 30(9). PMID: 22331951    Free PMC article.
Highly Cited.
Evaluation of a group cognitive behavioural intervention for women suffering from menopausal symptoms following breast cancer treatment.
Myra S Hunter, Shirley Coventry, +2 authors, Elizabeth A Grunfeld.
Psychooncology, 2008 Jul 23; 18(5). PMID: 18646246
Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers.
Xiao-Cheng Wu, Mary Jo Lund, +8 authors, Joseph Lipscomb.
J Clin Oncol, 2011 Dec 08; 30(2). PMID: 22147735
Predictors of non-adherence to aromatase inhibitors among commercially insured women with breast cancer.
Rebecca L Sedjo, Scott Devine.
Breast Cancer Res Treat, 2010 May 25; 125(1). PMID: 20495864
American society of clinical oncology clinical practice guideline update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer.
Harold J Burstein, Jennifer J Griggs, Ann A Prestrud, Sarah Temin.
J Oncol Pract, 2011 Jan 05; 6(5). PMID: 21197188    Free PMC article.
Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer.
Cynthia Owusu, Diana S M Buist, +9 authors, Rebecca A Silliman.
J Clin Oncol, 2007 Dec 12; 26(4). PMID: 18071188
Effectively nursing patients receiving aromatase inhibitor therapy.
Y Wengström.
Breast, 2007 Dec 14; 17(3). PMID: 18077168
Surveillance of demographic characteristics and health behaviors among adult cancer survivors--Behavioral Risk Factor Surveillance System, United States, 2009.
J Michael Underwood, Julie S Townsend, +16 authors, Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention (CDC).
MMWR Surveill Summ, 2012 Jan 20; 61(1). PMID: 22258477
Highly Cited.
Transition from treatment to survivorship: effects of a psychoeducational intervention on quality of life in breast cancer survivors.
Karen Dow Meneses, Patrick McNees, +3 authors, Lauren A Hassey.
Oncol Nurs Forum, 2007 Sep 20; 34(5). PMID: 17878129
Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer.
V Ziller, M Kalder, +4 authors, P Hadji.
Ann Oncol, 2009 Jan 20; 20(3). PMID: 19150950
Highly Cited.
Cognitive behavioural treatment for women who have menopausal symptoms after breast cancer treatment (MENOS 1): a randomised controlled trial.
Eleanor Mann, Melanie J Smith, +4 authors, Myra S Hunter.
Lancet Oncol, 2012 Feb 22; 13(3). PMID: 22340966    Free PMC article.
Adherence beliefs among breast cancer patients taking tamoxifen.
Elizabeth A Grunfeld, Myra S Hunter, Pooja Sikka, Sangeeta Mittal.
Patient Educ Couns, 2005 Oct 04; 59(1). PMID: 16198223
A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.
Paul E Goss, James N Ingle, +15 authors, Joseph L Pater.
N Engl J Med, 2003 Oct 11; 349(19). PMID: 14551341
Highly Cited.
Arthralgia during aromatase inhibitor treatment in early breast cancer patients: prevalence, impact, and recognition by healthcare providers.
Amilie Boonstra, Joost van Zadelhoff, +3 authors, Hanneke W M van Laarhoven.
Cancer Nurs, 2012 Apr 13; 36(1). PMID: 22495502
A checklist for medication compliance and persistence studies using retrospective databases.
Andrew M Peterson, David P Nau, +3 authors, Michael Nichol.
Value Health, 2007 Jan 31; 10(1). PMID: 17261111
Highly Cited.
Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors.
B Fisher, J Dignam, +18 authors, H L Lickley.
J Natl Cancer Inst, 1996 Nov 06; 88(21). PMID: 8901851
Highly Cited.
Early discontinuation of tamoxifen intake in younger women with breast cancer: is it time to rethink the way it is prescribed?
Laetitia Huiart, Anne-Déborah Bouhnik, +5 authors, Roch Giorgi.
Eur J Cancer, 2012 Apr 03; 48(13). PMID: 22464016
Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer.
Ann H Partridge, Philip S Wang, Eric P Winer, Jerry Avorn.
J Clin Oncol, 2003 Feb 15; 21(4). PMID: 12586795
Highly Cited.
Target and reality of adjuvant endocrine therapy in postmenopausal patients with invasive breast cancer.
U Güth, D J Huang, +4 authors, E Wight.
Br J Cancer, 2008 Jul 31; 99(3). PMID: 18665168    Free PMC article.
Adherence to endocrine therapy for breast cancer.
Rowan T Chlebowski, Michelle L Geller.
Oncology, 2007 Mar 09; 71(1-2). PMID: 17344666
Effect of concomitant CYP2D6 inhibitor use and tamoxifen adherence on breast cancer recurrence in early-stage breast cancer.
Vincent O Dezentjé, Nico J C van Blijderveen, +6 authors, Henk-Jan Guchelaar.
J Clin Oncol, 2010 Apr 14; 28(14). PMID: 20385997
A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer.
R Charles Coombes, Emma Hall, +24 authors, Intergroup Exemestane Study.
N Engl J Med, 2004 Mar 12; 350(11). PMID: 15014181
Highly Cited.
Changes in adherence to statins and subsequent lipid profiles during and following breast cancer treatment.
Gregory S Calip, Denise M Boudreau, Elizabeth T Loggers.
Breast Cancer Res Treat, 2013 Jan 30; 138(1). PMID: 23358904    Free PMC article.
Medication use in breast cancer survivors compared to midlife women.
Julie L Otte, Todd C Skaar, +4 authors, Janet S Carpenter.
Support Care Cancer, 2013 Feb 12; 21(7). PMID: 23397094    Free PMC article.
Influence of compliance on bone mineral density changes in postmenopausal women with early breast cancer on Anastrozole.
Matthias Kalder, Volker Ziller, +3 authors, Peyman Hadji.
J Cancer Res Clin Oncol, 2013 Feb 28; 139(6). PMID: 23443254
Endocrine therapy for postmenopausal women with hormone receptor-positive her2-negative advanced breast cancer after progression or recurrence on nonsteroidal aromatase inhibitor therapy: a Canadian consensus statement.
K I Pritchard, K A Gelmon, +4 authors, S Verma.
Curr Oncol, 2013 Feb 28; 20(1). PMID: 23443928    Free PMC article.
Adherence and discontinuation of oral hormonal therapy in patients with hormone receptor positive breast cancer.
Lorena Rocha Ayres, André de Oliveira Baldoni, Anna Paula de Sá Borges, Leonardo Régis Leira Pereira.
Int J Clin Pharm, 2013 Aug 13; 36(1). PMID: 23934310
Patient demographic and tumor characteristics influencing oncologist follow-up frequency in older breast cancer survivors.
Heather B Neuman, Jennifer M Weiss, +5 authors, Caprice C Greenberg.
Ann Surg Oncol, 2013 Aug 15; 20(13). PMID: 23943027    Free PMC article.
The value of high adherence to tamoxifen in women with breast cancer: a community-based cohort study.
C McCowan, S Wang, +2 authors, D J Petrie.
Br J Cancer, 2013 Aug 21; 109(5). PMID: 23949153    Free PMC article.
Factors associated with compliance to adjuvant hormone therapy in Black and White women with breast cancer.
Sumita S Bhatta, Ningqi Hou, +5 authors, Susan Hong.
Springerplus, 2013 Aug 21; 2. PMID: 23961419    Free PMC article.
Influence of a patient information program on adherence and persistence with an aromatase inhibitor in breast cancer treatment--the COMPAS study.
Volker Ziller, Ioannis Kyvernitakis, +3 authors, Peyman Hadji.
BMC Cancer, 2013 Sep 07; 13. PMID: 24006873    Free PMC article.
Early discontinuation of adjuvant hormone therapy is associated with a poor prognosis in Japanese breast cancer patients.
Kenji Taketani, Eriko Tokunaga, +10 authors, Yoshihiko Maehara.
Surg Today, 2013 Oct 22; 44(10). PMID: 24142101    Free PMC article.
Ethnic disparities in adherence to breast cancer survivorship surveillance care.
Pragati S Advani, Jun Ying, +7 authors, Abenaa M Brewster.
Cancer, 2013 Nov 22; 120(6). PMID: 24258799    Free PMC article.
Prospective associations of depression with survival: a population-based cohort study in patients with newly diagnosed breast cancer.
Andrea Vodermaier, Wolfgang Linden, +4 authors, Robert Olson.
Breast Cancer Res Treat, 2013 Dec 18; 143(2). PMID: 24337537    Free PMC article.
Complementary or alternative medicine as possible determinant of decreased persistence to aromatase inhibitor therapy among older women with non-metastatic breast cancer.
Laetitia Huiart, Anne-Deborah Bouhnik, +6 authors, Roch Giorgi.
PLoS One, 2013 Dec 25; 8(12). PMID: 24367488    Free PMC article.
A Narrative Review of the Confluence of Breast Cancer and Low-wage Employment and Its Impact on Receipt of Guideline-recommended Treatment.
Robin C Vanderpool, Jennifer E Swanberg, Mara D Chambers.
Glob Adv Health Med, 2014 Jan 15; 2(5). PMID: 24416698    Free PMC article.
Interruption and non-adherence to long-term adjuvant hormone therapy is associated with adverse survival outcome of breast cancer women--an Asian population-based study.
Kun-Pin Hsieh, Li-Chia Chen, +2 authors, Yi-Hsin Yang.
PLoS One, 2014 Mar 04; 9(2). PMID: 24586261    Free PMC article.
Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update.
Harold J Burstein, Sarah Temin, +10 authors, Jennifer J Griggs.
J Clin Oncol, 2014 May 29; 32(21). PMID: 24868023    Free PMC article.
Highly Cited.
Adherence to hormone therapy among women with breast cancer.
Claudia Brito, Margareth Crisóstomo Portela, Mauricio Teixeira Leite de Vasconcellos.
BMC Cancer, 2014 Jun 05; 14. PMID: 24893670    Free PMC article.
Factors associated to persistence with hormonal therapy in women with breast cancer.
Cláudia Brito, Margareth Crisóstomo Portela, Mauricio Teixeira Leite de Vasconcellos.
Rev Saude Publica, 2014 Jun 05; 48(2). PMID: 24897050    Free PMC article.
A hard pill to swallow: a qualitative study of women's experiences of adjuvant endocrine therapy for breast cancer.
Alison Harrow, Ruth Dryden, +4 authors, Mary Wells.
BMJ Open, 2014 Jun 15; 4(6). PMID: 24928595    Free PMC article.
Frailty and adherence to adjuvant hormonal therapy in older women with breast cancer: CALGB protocol 369901.
Vanessa B Sheppard, Leigh Anne Faul, +14 authors, Jeanne S Mandelblatt.
J Clin Oncol, 2014 Jun 18; 32(22). PMID: 24934786    Free PMC article.
Early discontinuation of endocrine therapy for breast cancer: who is at risk in clinical practice?
Anna Kemp, David B Preen, +4 authors, Elizabeth E Roughead.
Springerplus, 2014 Jun 18; 3. PMID: 24936397    Free PMC article.
Psychosocial factors in adjuvant hormone therapy for breast cancer: an emerging context for adherence research.
Julia R Van Liew, Alan J Christensen, Janet S de Moor.
J Cancer Surviv, 2014 Jul 06; 8(3). PMID: 24986227
Systematic Review.
Discontinuation and non-adherence to endocrine therapy in breast cancer patients: is lack of communication the decisive factor?
P Wuensch, A Hahne, +5 authors, J Huebner.
J Cancer Res Clin Oncol, 2014 Aug 03; 141(1). PMID: 25085010
Sexual problems during the first 2 years of adjuvant treatment with aromatase inhibitors.
Leslie R Schover, George P Baum, +2 authors, Amal Melhem-Bertrandt.
J Sex Med, 2014 Aug 22; 11(12). PMID: 25141792    Free PMC article.
Rapid modulation of aromatase activity in the vertebrate brain.
Thierry D Charlier, Charlotte A Cornil, Jacques Balthazart.
J Exp Neurosci, 2013 Jan 01; 7. PMID: 25157205    Free PMC article.
Perspectives of postmenopausal breast cancer survivors on adjuvant endocrine therapy-related symptoms.
G J van Londen, Heidi S Donovan, +7 authors, Mary Amanda Dew.
Oncol Nurs Forum, 2014 Oct 31; 41(6). PMID: 25355021    Free PMC article.
Biology of breast cancer in young women.
Hatem A Azim, Ann H Partridge.
Breast Cancer Res, 2014 Dec 02; 16(4). PMID: 25436920    Free PMC article.
Highly Cited. Review.
Randomized exercise trial of aromatase inhibitor-induced arthralgia in breast cancer survivors.
Melinda L Irwin, Brenda Cartmel, +13 authors, Jennifer Ligibel.
J Clin Oncol, 2014 Dec 03; 33(10). PMID: 25452437    Free PMC article.
Acceptance and adherence to chemoprevention among women at increased risk of breast cancer.
Richard G Roetzheim, Ji-Hyun Lee, +7 authors, John V Kiluk.
Breast, 2014 Dec 11; 24(1). PMID: 25491191    Free PMC article.
Patient preferences and treatment adherence among women diagnosed with metastatic breast cancer.
Marco daCosta DiBonaventura, Ronda Copher, +2 authors, Rose Lorenzo.
Am Health Drug Benefits, 2014 Dec 20; 7(7). PMID: 25525495    Free PMC article.
Psychosocial correlates of appointment keeping in immigrant cancer patients.
Rosario Costas-Muniz, Jennifer Leng, +3 authors, Francesca Gany.
J Psychosoc Oncol, 2015 Jan 13; 33(2). PMID: 25574581    Free PMC article.
The impact of cancer prevention guideline adherence on overall mortality in a high-risk cohort of women from the New York site of the Breast Cancer Family Registry.
Ann J Cloud, Ashley Thai, Yuyan Liao, Mary Beth Terry.
Breast Cancer Res Treat, 2015 Jan 22; 149(2). PMID: 25604794    Free PMC article.
Women's experiences of hormonal therapy for breast cancer: exploring influences on medication-taking behaviour.
Caitriona Cahir, Stephan U Dombrowski, +3 authors, Linda Sharp.
Support Care Cancer, 2015 Mar 07; 23(11). PMID: 25744290
Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations.
Balazs I Bodai, Phillip Tuso.
Perm J, 2015 Apr 23; 19(2). PMID: 25902343    Free PMC article.
Racial/Ethnic and socioeconomic disparities in endocrine therapy adherence in breast cancer: a systematic review.
Megan C Roberts, Stephanie B Wheeler, Katherine Reeder-Hayes.
Am J Public Health, 2015 Apr 24; 105 Suppl 3. PMID: 25905855    Free PMC article.
Systematic Review.
Symptoms and Symptom Attribution Among Women on Endocrine Therapy for Breast Cancer.
Shoshana M Rosenberg, Annette L Stanton, Keith J Petrie, Ann H Partridge.
Oncologist, 2015 May 03; 20(6). PMID: 25933930    Free PMC article.
Targeted Therapies in Breast Cancer: Implications for Advanced Oncology Practice.
Laura Bourdeanu, Thehan Luu.
J Adv Pract Oncol, 2015 Jun 26; 5(4). PMID: 26110069    Free PMC article.
Adjuvant therapy use among Appalachian breast cancer survivors.
Xi Tan, Vincent D Marshall, +3 authors, Rajesh Balkrishnan.
Medicine (Baltimore), 2015 Jul 02; 94(26). PMID: 26131828    Free PMC article.
Application status of tamoxifen in endocrine therapy for early breast cancer.
Qiancheng Hu, Ting Luo, +3 authors, Hong Zheng.
Exp Ther Med, 2015 Jul 03; 9(6). PMID: 26136961    Free PMC article.
Medication taking behaviors among breast cancer patients on adjuvant endocrine therapy.
Gretchen Kimmick, Sara N Edmond, +5 authors, Rebecca A Shelby.
Breast, 2015 Jul 21; 24(5). PMID: 26189978    Free PMC article.
Local and Systemic Therapies for Breast Cancer Patients: Reducing Short-term Symptoms with the Methods of Integrative Medicine.
C C Hack, P Voiß, +5 authors, S Kümmel.
Geburtshilfe Frauenheilkd, 2015 Aug 11; 75(7). PMID: 26257404    Free PMC article.
Triple negative breast cancer: looking for the missing link between biology and treatments.
Giuseppe Palma, Giuseppe Frasci, +7 authors, Massimiliano D'Aiuto.
Oncotarget, 2015 Sep 21; 6(29). PMID: 26387133    Free PMC article.
Highly Cited. Review.
Medication use by early-stage breast cancer survivors: a 1-year longitudinal study.
Kep Yong Loh, Terence Ng, +2 authors, Alexandre Chan.
Support Care Cancer, 2015 Sep 26; 24(4). PMID: 26404861    Free PMC article.
Double-Blind, Randomized Trial of Alternative Letrozole Dosing Regimens in Postmenopausal Women with Increased Breast Cancer Risk.
Ana Maria López, Sandhya Pruthi, +7 authors, H-H Sherry Chow.
Cancer Prev Res (Phila), 2015 Dec 17; 9(2). PMID: 26667449    Free PMC article.
Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study.
Hannah Arem, Mia Sorkin, +12 authors, Melinda L Irwin.
J Cancer Surviv, 2016 Jan 20; 10(4). PMID: 26782031    Free PMC article.
Perceptions, Attributions, and Emotions Toward Endocrine Therapy in Young Women with Breast Cancer.
Hayley E Walker, Shoshana M Rosenberg, +2 authors, Ann H Partridge.
J Adolesc Young Adult Oncol, 2016 Jan 27; 5(1). PMID: 26812461    Free PMC article.
Effects of a nurse-led medication self-management programme in cancer patients: protocol for a mixed-method randomised controlled trial.
Hiroko Komatsu, Kaori Yagasaki, Takuhiro Yamaguchi.
BMC Nurs, 2016 Feb 10; 15. PMID: 26858582    Free PMC article.
A Systematic Review of Adherence to Oral Antineoplastic Therapies.
Joseph A Greer, Nicole Amoyal, +7 authors, William F Pirl.
Oncologist, 2016 Feb 28; 21(3). PMID: 26921292    Free PMC article.
Systematic Review.
Patient-Reported Outcomes and Early Discontinuation in Aromatase Inhibitor-Treated Postmenopausal Women With Early Stage Breast Cancer.
Kunal C Kadakia, Claire F Snyder, +11 authors, N Lynn Henry.
Oncologist, 2016 Mar 25; 21(5). PMID: 27009936    Free PMC article.
Comparison of Clinicopathological Features and Treatments between Young (≤40 Years) and Older (>40 Years) Female Breast Cancer Patients in West China: A Retrospective, Epidemiological, Multicenter, Case Only Study.
Ke Wang, Yu Ren, +11 authors, Guosheng Ren.
PLoS One, 2016 Apr 01; 11(3). PMID: 27031236    Free PMC article.
Adjuvant endocrine therapy in premenopausal women with breast cancer.
Kunal C Kadakia, N Lynn Henry.
Clin Adv Hematol Oncol, 2016 Apr 09; 13(10). PMID: 27058571    Free PMC article.
Racial differences in receipt of adjuvant hormonal therapy among Medicaid enrollees in South Carolina diagnosed with breast cancer.
Tisha M Felder, D Phuong Do, +3 authors, Charles L Bennett.
Breast Cancer Res Treat, 2016 Apr 28; 157(1). PMID: 27120468    Free PMC article.
Behavioral Interventions to Enhance Adherence to Hormone Therapy in Breast Cancer Survivors: A Systematic Literature Review.
Alejandra Hurtado-de-Mendoza, Mark L Cabling, +2 authors, Vanessa B Sheppard.
Clin Breast Cancer, 2016 May 03; 16(4). PMID: 27133733    Free PMC article.
Systematic Review.
Barriers and facilitators to endocrine therapy adherence among underserved hormone-receptor-positive breast cancer survivors: a qualitative study.
Kristen J Wells, Tonya M Pan, +12 authors, Gwendolyn P Quinn.
Support Care Cancer, 2016 May 06; 24(10). PMID: 27146492    Free PMC article.
Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence.
Jacquie H Chirgwin, Anita Giobbie-Hurder, +12 authors, Beat Thürlimann.
J Clin Oncol, 2016 May 25; 34(21). PMID: 27217455    Free PMC article.
Highly Cited.
Effect of selective serotonin reuptake inhibitors use on endocrine therapy adherence and breast cancer mortality: a population-based study.
Antonis Valachis, Hans Garmo, +4 authors, Lars Holmberg.
Breast Cancer Res Treat, 2016 Aug 06; 159(2). PMID: 27492739    Free PMC article.
Perceived barriers to treatment predict adherence to aromatase inhibitors among breast cancer survivors.
Moriah J Brier, Dianne L Chambless, +2 authors, Jun J Mao.
Cancer, 2016 Aug 30; 123(1). PMID: 27570979    Free PMC article.
Persistence to 5-year hormonal breast cancer therapy: a French national population-based study.
Pauline Bosco-Lévy, Jeremy Jové, +3 authors, Julien Bezin.
Br J Cancer, 2016 Sep 07; 115(8). PMID: 27599040    Free PMC article.
"Winging It": How Older Breast Cancer Survivors Persist With Aromatase Inhibitor Treatment.
Eden R Brauer, Patricia A Ganz, Huibrie C Pieters.
J Oncol Pract, 2016 Sep 15; 12(12). PMID: 27624945    Free PMC article.
Geographic disparities in adherence to adjuvant endocrine therapy in Appalachian women with breast cancer.
Xi Tan, Fabian Camacho, +3 authors, Rajesh Balkrishnan.
Res Social Adm Pharm, 2016 Sep 20; 13(4). PMID: 27641308    Free PMC article.
Oncology providers' perspectives on endocrine therapy prescribing and management.
Stephanie B Wheeler, Megan C Roberts, +5 authors, Jo Anne Earp.
Patient Prefer Adherence, 2016 Oct 21; 10. PMID: 27757021    Free PMC article.
The Association Between Out-of-Pocket Costs and Adherence to Adjuvant Endocrine Therapy Among Newly Diagnosed Breast Cancer Patients.
Albert J Farias, Ryan N Hansen, +3 authors, Beti Thompson.
Am J Clin Oncol, 2016 Nov 29; 41(7). PMID: 27893470    Free PMC article.
Cytochrome P-450 2D6 (CYP2D6) Genotype and Breast Cancer Recurrence in Tamoxifen-Treated Patients: Evaluating the Importance of Loss of Heterozygosity.
Thomas P Ahern, Daniel L Hertz, +7 authors, Deirdre P Cronin-Fenton.
Am J Epidemiol, 2016 Dec 19; 185(2). PMID: 27988492    Free PMC article.
Factors Associated With Tyrosine Kinase Inhibitor Initiation and Adherence Among Medicare Beneficiaries With Chronic Myeloid Leukemia.
Aaron N Winn, Nancy L Keating, Stacie B Dusetzina.
J Clin Oncol, 2016 Dec 22; 34(36). PMID: 27998234    Free PMC article.
The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors.
Gwendolyn A Thomas, Brenda Cartmel, +11 authors, Melinda L Irwin.
Obesity (Silver Spring), 2016 Dec 28; 25(2). PMID: 28026901    Free PMC article.
Dasatinib inhibits c-src phosphorylation and prevents the proliferation of Triple-Negative Breast Cancer (TNBC) cells which overexpress Syndecan-Binding Protein (SDCBP).
Xiao-Long Qian, Jun Zhang, +7 authors, Li Fu.
PLoS One, 2017 Feb 01; 12(1). PMID: 28141839    Free PMC article.
Evaluation of the Quality of Adjuvant Endocrine Therapy Delivery for Breast Cancer Care in the United States.
Bobby Daly, Olufunmilayo I Olopade, +3 authors, Dezheng Huo.
JAMA Oncol, 2017 Feb 06; 3(7). PMID: 28152150    Free PMC article.
An update on the management of breast cancer in Africa.
V Vanderpuye, S Grover, +4 authors, D C Stefan.
Infect Agent Cancer, 2017 Feb 24; 12. PMID: 28228841    Free PMC article.
Barriers and facilitators of adjuvant hormone therapy adherence and persistence in women with breast cancer: a systematic review.
Zoe Moon, Rona Moss-Morris, +2 authors, Lyndsay D Hughes.
Patient Prefer Adherence, 2017 Mar 07; 11. PMID: 28260867    Free PMC article.
High Initiation of Adjuvant Hormonal Therapy Among Uninsured Stages I-III Breast Cancer Patients Treated in a Safety-Net Healthcare System.
Caitlin C Murphy, Jasmin A Tiro, +2 authors, Carlos A Alvarez.
J Womens Health (Larchmt), 2017 Mar 16; 26(6). PMID: 28296574    Free PMC article.
A prospective study of aromatase inhibitor therapy initiation and self-reported side effects.
Lisa Gallicchio, Carla Calhoun, Kathy Helzlsouer.
Support Care Cancer, 2017 Mar 28; 25(9). PMID: 28341972
Endocrine therapy initiation, discontinuation and adherence and breast imaging among 21-gene recurrence score assay-eligible women under age 65.
Suzanne C O'Neill, Claudine Isaacs, +8 authors, Arnold L Potosky.
Breast Cancer Res, 2017 Apr 01; 19(1). PMID: 28359319    Free PMC article.
Patients' support for health information exchange: a literature review and classification of key factors.
Pouyan Esmaeilzadeh, Murali Sambasivan.
BMC Med Inform Decis Mak, 2017 Apr 06; 17(1). PMID: 28376785    Free PMC article.
Urban-Rural Variations in Quality-of-Life in Breast Cancer Survivors Prescribed Endocrine Therapy.
Caitriona Cahir, Audrey Alforque Thomas, +2 authors, Linda Sharp.
Int J Environ Res Public Health, 2017 Apr 08; 14(4). PMID: 28387748    Free PMC article.
Adjuvant Endocrine Therapy in Breast Cancer: Evolving Paradigms in Premenopausal Women.
Lorenzo Rossi, Olivia Pagani.
Curr Treat Options Oncol, 2017 Apr 26; 18(5). PMID: 28439796
Predicting Adherence to Aromatase Inhibitor Therapy among Breast Cancer Survivors: An Application of the Protection Motivation Theory.
Monita Karmakar, Sharrel L Pinto, +2 authors, Monica Holiday-Goodman.
Breast Cancer (Auckl), 2017 May 05; 11. PMID: 28469437    Free PMC article.
Effect of Adherence on Pharmacokinetic/Pharmacodynamic Relationships of Oral Targeted Anticancer Drugs.
Evelina Cardoso, Chantal Csajka, Marie P Schneider, Nicolas Widmer.
Clin Pharmacokinet, 2017 Jun 22; 57(1). PMID: 28634655
Deconstructing Decisions to Initiate, Maintain, or Discontinue Adjuvant Endocrine Therapy in Breast Cancer Survivors: A Mixed-Methods Study.
Shirley M Bluethmann, Caitlin C Murphy, +3 authors, Leona Kay Bartholomew.
Oncol Nurs Forum, 2017 Jun 22; 44(3). PMID: 28635973    Free PMC article.
Variable aromatase inhibitor plasma concentrations do not correlate with circulating estrogen concentrations in post-menopausal breast cancer patients.
Daniel L Hertz, Kelly A Speth, +8 authors, James M Rae.
Breast Cancer Res Treat, 2017 Jun 24; 165(3). PMID: 28643023    Free PMC article.
Cognitive function and discontinuation of adjuvant hormonal therapy in older breast cancer survivors: CALGB 369901 (Alliance).
Shirley M Bluethmann, Catherine M Alfano, +8 authors, Jeanne S Mandelblatt.
Breast Cancer Res Treat, 2017 Jun 28; 165(3). PMID: 28653250    Free PMC article.
Sentiment Analysis of an Online Breast Cancer Support Group: Communicating about Tamoxifen.
Mark L Cabling, Jeanine W Turner, +4 authors, Vanessa B Sheppard.
Health Commun, 2017 Jul 06; 33(9). PMID: 28678549    Free PMC article.
Perceptions of Support Groups Among Older Breast Cancer Survivors: "I've Heard of Them, but I've Never Felt the Need to Go".
Emily K Green, Amelework Wodajo, +2 authors, Huibrie C Pieters.
Cancer Nurs, 2017 Aug 15; 41(6). PMID: 28806304    Free PMC article.
Impact of the OATP1B1 c.521T>C single nucleotide polymorphism on the pharmacokinetics of exemestane in healthy post-menopausal female volunteers.
B J Gregory, S M Chen, +2 authors, L K Kamdem.
J Clin Pharm Ther, 2017 Sep 05; 42(5). PMID: 28868654    Free PMC article.
Prevalence and Determinants of Adherence to Oral Adjuvant Endocrine Therapy among Breast Cancer Patients in Singapore.
Eskinder Eshetu Ali, Ka Lok Cheung, +3 authors, Lita Chew.
Asia Pac J Oncol Nurs, 2017 Oct 03; 4(4). PMID: 28966955    Free PMC article.
Quality of life and impact of pain in women treated with aromatase inhibitors for breast cancer. A multicenter cohort study.
Françoise Laroche, Serge Perrot, +8 authors, Joël Coste.
PLoS One, 2017 Nov 09; 12(11). PMID: 29117210    Free PMC article.
Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up.
Hege O Ohnstad, Elin Borgen, +11 authors, Bjørn Naume.
Breast Cancer Res, 2017 Nov 16; 19(1). PMID: 29137653    Free PMC article.
Impact of persistence on survival of patients with breast cancer treated with endocrine therapy in Northeast China: a prospective study.
Peng Xing, Huiting Dong, +7 authors, Jiguang Li.
Oncotarget, 2017 Dec 20; 8(60). PMID: 29254265    Free PMC article.
Facilitating adherence to endocrine therapy in breast cancer: stability and predictive power of treatment expectations in a 2-year prospective study.
Yiqi Pan, Sarah R Heisig, +4 authors, Yvonne Nestoriuc.
Breast Cancer Res Treat, 2018 Jan 14; 168(3). PMID: 29330625    Free PMC article.
Interventions to improve endocrine therapy adherence in breast cancer survivors: what is the evidence?
Ekim Ekinci, Salima Nathoo, +5 authors, Meghana V Trivedi.
J Cancer Surviv, 2018 Feb 06; 12(3). PMID: 29396760
Analysis of information received during treatment and adherence to tamoxifen in breast cancer patients.
Aline Cruz, Aline Rodrigues, +3 authors, Priscila Mazzola.
Contemp Oncol (Pozn), 2018 Feb 09; 21(4). PMID: 29416436    Free PMC article.
Use of a web-based app to improve breast cancer symptom management and adherence for aromatase inhibitors: a randomized controlled feasibility trial.
Ilana Graetz, Caitlin N McKillop, +3 authors, Lee S Schwartzberg.
J Cancer Surviv, 2018 Mar 02; 12(4). PMID: 29492753    Free PMC article.
Adjuvant endocrine therapy after breast cancer: a qualitative study of factors associated with adherence.
Jo Brett, Mary Boulton, +7 authors, Eila K Watson.
Patient Prefer Adherence, 2018 Mar 03; 12. PMID: 29497284    Free PMC article.
Relationships between determinants of adjuvant endocrine therapy adherence in breast cancer.
Joo Yun Lee, Yul Ha Min.
BMC Womens Health, 2018 Mar 20; 18(1). PMID: 29551094    Free PMC article.
Estrogenicity of essential oils is not required to relieve symptoms of urogenital atrophy in breast cancer survivors.
Bruno M Simões, Bertram Kohler, +7 authors, Sacha J Howell.
Ther Adv Med Oncol, 2018 Apr 11; 10. PMID: 29636827    Free PMC article.
Personal and clinical social support and adherence to adjuvant endocrine therapy among hormone receptor-positive breast cancer patients in an integrated health care system.
Candyce H Kroenke, Dawn L Hershman, +6 authors, Lawrence H Kushi.
Breast Cancer Res Treat, 2018 Apr 20; 170(3). PMID: 29671113    Free PMC article.
Current Status of Extended Adjuvant Endocrine Therapy in Early Stage Breast Cancer.
Irene E G van Hellemond, Sandra M E Geurts, Vivianne C G Tjan-Heijnen.
Curr Treat Options Oncol, 2018 Apr 29; 19(5). PMID: 29704066    Free PMC article.
Physical Activity and Breast Cancer: an Opportunity to Improve Outcomes.
Lindsay L Peterson, Jennifer A Ligibel.
Curr Oncol Rep, 2018 May 02; 20(7). PMID: 29713835
Talking About My Care: Detecting Mentions of Hormonal Therapy Adherence Behavior in an Online Breast Cancer Community.
Zhijun Yin, Wei Xie, Bradley A Malin.
AMIA Annu Symp Proc, 2018 Jun 02; 2017. PMID: 29854258    Free PMC article.
A Social Cognitive Theory-based Framework for Monitoring Medication Adherence Applied to Endocrine Therapy in Breast Cancer Survivors.
Mehdi Boukhechba, Sonia Baee, +3 authors, Laura E Barnes.
IEEE EMBS Int Conf Biomed Health Inform, 2018 Jun 05; 2018. PMID: 29862383    Free PMC article.
Women's Beliefs on Early Adherence to Adjuvant Endocrine Therapy for Breast Cancer: A Theory-Based Qualitative Study to Guide the Development of Community Pharmacist Interventions.
Brittany Humphries, Stéphanie Collins, +5 authors, Sophie Lauzier.
Pharmacy (Basel), 2018 Jun 13; 6(2). PMID: 29890738    Free PMC article.
Improving medication adherence with adjuvant aromatase inhibitor in women with breast cancer: study protocol of a randomised controlled trial to evaluate the effect of short message service (SMS) reminder.
Yunxin He, Eng Hooi Tan, +4 authors, Bee Choo Tai.
BMC Cancer, 2018 Jul 11; 18(1). PMID: 29986672    Free PMC article.
Understanding adjuvant endocrine therapy persistence in breast Cancer survivors.
Leah K Lambert, Lynda G Balneaves, +2 authors, Carolyn C Gotay.
BMC Cancer, 2018 Jul 13; 18(1). PMID: 29996816    Free PMC article.
A conceptual model of social networks and mechanisms of cancer mortality, and potential strategies to improve survival.
Candyce H Kroenke.
Transl Behav Med, 2018 Jul 18; 8(4). PMID: 30016520    Free PMC article.
Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: the role of comorbidity.
W Wulaningsih, H Garmo, +5 authors, M Lambe.
Breast Cancer Res Treat, 2018 Jul 22; 172(1). PMID: 30030708    Free PMC article.
Extended duration of adjuvant aromatase inhibitor in breast cancer: a meta-analysis of randomized controlled trials.
Zackariah Clement, James Kollias, +2 authors, Melissa Bochner.
Gland Surg, 2018 Dec 07; 7(5). PMID: 30505766    Free PMC article.
Endocrine-related quality of life in a randomized trial of exercise on aromatase inhibitor-induced arthralgias in breast cancer survivors.
Michelle L Baglia, I-Hsin Lin, +7 authors, Melinda L Irwin.
Cancer, 2019 Mar 07; 125(13). PMID: 30840336    Free PMC article.
Exploring the role of social support and adjuvant endocrine therapy use among breast cancer survivors.
Gabriela Toledo, Carol Y Ochoa, Albert J Farias.
Support Care Cancer, 2019 May 01; 28(1). PMID: 31037379    Free PMC article.
Endocrine therapy in the years following a diagnosis of breast cancer: A proof of concept study using the primary care prescription database linked to cancer registration data.
Gabrielle Emanuel, Katherine E Henson, +4 authors, Sarah C Darby.
Cancer Epidemiol, 2019 May 28; 61. PMID: 31126816    Free PMC article.
Cost-utility, cost-effectiveness, and budget impact of Internet-based cognitive behavioral therapy for breast cancer survivors with treatment-induced menopausal symptoms.
Joost G E Verbeek, Vera Atema, +7 authors, Valesca P Retèl.
Breast Cancer Res Treat, 2019 Aug 28; 178(3). PMID: 31451978    Free PMC article.
Increasing Adherence to Adjuvant Hormone Therapy Among Patients With Breast Cancer: A Smart Phone App-Based Pilot Study.
Jessica L Krok-Schoen, Michelle J Naughton, +7 authors, Douglas M Post.
Cancer Control, 2019 Nov 19; 26(1). PMID: 31736324    Free PMC article.
THRIVE study protocol: a randomized controlled trial evaluating a web-based app and tailored messages to improve adherence to adjuvant endocrine therapy among women with breast cancer.
Andrew J Paladino, Janeane N Anderson, +9 authors, Ilana Graetz.
BMC Health Serv Res, 2019 Dec 21; 19(1). PMID: 31856812    Free PMC article.
A Systematic Review of Repeat Fecal Occult Blood Tests for Colorectal Cancer Screening.
Caitlin C Murphy, Ahana Sen, +3 authors, Amit G Singal.
Cancer Epidemiol Biomarkers Prev, 2019 Nov 20; 29(2). PMID: 31740521    Free PMC article.
Systematic Review.
Analysis of Adjuvant Endocrine Therapy in Practice From Electronic Health Record Data of Patients With Breast Cancer.
Morgan Harrell, Daniel Fabbri, Mia Levy.
JCO Clin Cancer Inform, 2017 Nov 01; 1. PMID: 30657375    Free PMC article.
Aromatase inhibitors: The unexpected breast cancer treatment.
Huibrie C Pieters, Emily Green, Miriam Sleven, Annette L Stanton.
J Geriatr Oncol, 2019 Sep 01; 11(3). PMID: 31471170    Free PMC article.
Omission of postoperative radiation after breast conserving surgery: A progressive paradigm shift towards precision medicine.
Pierfrancesco Franco, Fiorenza De Rose, +5 authors, Clinical Oncology Breast Cancer Group (COBCG) Investigators.
Clin Transl Radiat Oncol, 2020 Feb 25; 21. PMID: 32090175    Free PMC article.
Lumpectomy Plus Hormone or Radiation Therapy Alone for Women Aged 70 Years or Older With Hormone Receptor-Positive Early Stage Breast Cancer in the Modern Era: An Analysis of the National Cancer Database.
Samantha M Buszek, Heather Y Lin, +4 authors, Simona F Shaitelman.
Int J Radiat Oncol Biol Phys, 2019 Aug 05; 105(4). PMID: 31377160    Free PMC article.
Prognostic factors of adjuvant chemotherapy discontinuation among stage III colon cancer patients: A survey of medical oncologists and a systematic review and meta-analysis.
Devon J Boyne, Dylan E O'Sullivan, +5 authors, Christine M Friedenreich.
Cancer Med, 2020 Jan 22; 9(5). PMID: 31962372    Free PMC article.
Systematic Review.
Learning When Communications Between Healthcare Providers Indicate Hormonal Therapy Medication Discontinuation.
Zhijun Yin, Jeremy L Warner, Bradley A Malin.
AMIA Annu Symp Proc, 2019 Mar 01; 2018. PMID: 30815205    Free PMC article.
Predicting the Benefit of Adjuvant Aromatase Inhibitor Therapy in Postmenopausal Breast Cancer Patients with Phosphorylated S6K1 Expression Status.
Jihye Choi, Chan Sub Park, +5 authors, Hyun-Ah Kim.
J Breast Cancer, 2020 Mar 07; 23(1). PMID: 32140266    Free PMC article.
Testing a behavioral intervention to improve adherence to adjuvant endocrine therapy (AET).
Rebecca A Shelby, Caroline S Dorfman, +12 authors, Gretchen Kimmick.
Contemp Clin Trials, 2018 Nov 26; 76. PMID: 30472215    Free PMC article.
Long-Term Survivorship Care After Cancer Treatment - Summary of a 2017 National Cancer Policy Forum Workshop.
Ronald M Kline, Neeraj K Arora, +9 authors, Patricia A Ganz.
J Natl Cancer Inst, 2018 Nov 30; 110(12). PMID: 30496448    Free PMC article.
Higher symptom burden is associated with lower function in women taking adjuvant endocrine therapy for breast cancer.
Andrea Sitlinger, Rebecca A Shelby, +6 authors, Gretchen G Kimmick.
J Geriatr Oncol, 2018 Dec 17; 10(2). PMID: 30553719    Free PMC article.
Effects of Jaeumkanghwa-tang on tamoxifen responsiveness in preclinical ER+ breast cancer model.
Fabia De Oliveira Andrade, Wei Yu, +5 authors, Leena Hilakivi-Clarke.
Endocr Relat Cancer, 2019 Jan 15; 26(3). PMID: 30640711    Free PMC article.
Topical treatment of vaginal dryness with a non-hormonal cream in women undergoing breast cancer treatment - An open prospective multicenter study.
Dimitrios Chatsiproios, Iris M Schmidts-Winkler, +2 authors, Christoph Abels.
PLoS One, 2019 Jan 25; 14(1). PMID: 30677065    Free PMC article.
Discontinuation of adjuvant hormone therapy among breast cancer patients not previously attending mammography screening.
Wei He, Louise Eriksson, +3 authors, Kamila Czene.
BMC Med, 2019 Feb 01; 17(1). PMID: 30700300    Free PMC article.
A qualitative comparison of how older breast cancer survivors process treatment information regarding endocrine therapy.
Huibrie C Pieters, Emily Green, +2 authors, Annette L Stanton.
PLoS One, 2019 Feb 01; 14(1). PMID: 30703119    Free PMC article.
Avoiding over- and undertreatment in patients with resected node-positive breast cancer with the use of gene expression signatures: are we there yet?
A Matikas, T Foukakis, S Swain, J Bergh.
Ann Oncol, 2019 May 28; 30(7). PMID: 31131397    Free PMC article.
Toward a health-promoting system for cancer survivors: Patient and provider multiple behavior change.
Bonnie Spring, Tammy Stump, +2 authors, June K Robinson.
Health Psychol, 2019 Aug 23; 38(9). PMID: 31436465    Free PMC article.
Tamoxifen-related endocrine symptoms in Chinese patients with breast cancer: Study protocol clinical trial (SPIRIT Compliant).
Carmen Wing Han Chan, Christine Miaskowski, +6 authors, Judy Yuet Wa Chan.
Medicine (Baltimore), 2020 Feb 23; 99(8). PMID: 32080081    Free PMC article.
Partner status moderates the relationships between sexual problems and self-efficacy for managing sexual problems and psychosocial quality-of-life for postmenopausal breast cancer survivors taking adjuvant endocrine therapy.
Caroline S Dorfman, Sarah S Arthur, +5 authors, Rebecca A Shelby.
Menopause, 2019 Apr 18; 26(8). PMID: 30994574    Free PMC article.
A systematic review of interventions to improve adherence to endocrine therapy.
Sue P Heiney, Pearman D Parker, +3 authors, Jennifer M Hulett.
Breast Cancer Res Treat, 2018 Nov 06; 173(3). PMID: 30387003    Free PMC article.
Systematic Review.
Adherence and Persistence to Adjuvant Hormonal Therapy in Early-Stage Breast Cancer Patients: A Population-Based Retrospective Cohort Study in Israel.
Tal Sella, Gabriel Chodick.
Breast Care (Basel), 2020 Apr 02; 15(1). PMID: 32231497    Free PMC article.
Acupuncture and Vitamin D for the Management of Aromatase Inhibitor-Induced Arthralgia.
Kartik Anand, Polly Niravath.
Curr Oncol Rep, 2019 Apr 19; 21(6). PMID: 30997616
Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT.
Olivia Pagani, Prudence A Francis, +13 authors, SOFT and TEXT Investigators and International Breast Cancer Study Group.
J Clin Oncol, 2019 Oct 17; 38(12). PMID: 31618131    Free PMC article.
Factors Associated with Endocrine Therapy Non-Adherence in Breast Cancer Survivors.
Jennifer C Spencer, Bryce B Reeve, Melissa A Troester, Stephanie B Wheeler.
Psychooncology, 2020 Feb 13; 29(4). PMID: 32048400    Free PMC article.
Validation of the 8th edition of the American Joint Committee on Cancer Pathological Prognostic Staging for young breast cancer patients.
Juan Zhou, Jian Lei, +4 authors, San-Gang Wu.
Aging (Albany NY), 2020 Apr 23; 12(8). PMID: 32320950    Free PMC article.
Adherence status to Adjuvant Endocrine Therapy in Chinese Women with Early Breast Cancer and its influencing factors: A cross-sectional survey.
Hui Xu, Feng Jin, +3 authors, Ai-Ping Wang.
Cancer Med, 2020 Apr 03; 9(11). PMID: 32237070    Free PMC article.
Impact of routine assessment of health-related quality of life coupled with therapeutic information on compliance with endocrine therapy in patients with non-metastatic breast cancer: protocol for a randomized controlled trial.
Ariane Mamguem Kamga, Cyril Di Martino, +5 authors, Tienhan Sandrine Dabakuyo-Yonli.
Trials, 2020 Jun 18; 21(1). PMID: 32546198    Free PMC article.
Sociodemographic, clinical, psychosocial, and healthcare-related factors associated with beliefs about adjuvant endocrine therapy among breast cancer survivors.
Arnethea L Sutton, Teresa M Salgado, +2 authors, Vanessa B Sheppard.
Support Care Cancer, 2020 Jan 04; 28(9). PMID: 31897782    Free PMC article.
Breast Cancer: Lifestyle, the Human Gut Microbiota/Microbiome, and Survivorship.
Balazs I Bodai, Therese E Nakata.
Perm J, 2020 Jun 27; 24. PMID: 32589577    Free PMC article.
Improving medication adherence with adjuvant aromatase inhibitor in women with breast cancer: A randomised controlled trial to evaluate the effect of short message service (SMS) reminder.
Eng Hooi Tan, Andrea Li Ann Wong, +8 authors, Bee Choo Tai.
Breast, 2020 Jul 12; 53. PMID: 32652462    Free PMC article.
Why individual-level interventions are not enough: Systems-level determinants of oral anticancer medication adherence.
Lorraine T Dean, Marshalee George, Kimberley T Lee, Kimlin Ashing.
Cancer, 2020 May 22; 126(16). PMID: 32438466    Free PMC article.
Does persistent use of radiation in women > 70 years of age with early-stage breast cancer reflect tailored patient-centered care?
Lauren J Taylor, Jennifer S Steiman, +4 authors, Heather B Neuman.
Breast Cancer Res Treat, 2020 Mar 04; 180(3). PMID: 32125557    Free PMC article.
The Potential for Mammographic Breast Density Change as a Biosensor of Adjuvant Tamoxifen Therapy Adherence and Response.
Maeve Mullooly, Gretchen L Gierach.
JNCI Cancer Spectr, 2019 Feb 13; 2(4). PMID: 30746510    Free PMC article.
Prescription Refill Gap of Endocrine Treatment from Electronic Medical Records as a Prognostic Factor in Breast Cancer Patients.
Yura Lee, Yu Rang Park, +5 authors, Jong Won Lee.
J Breast Cancer, 2019 Apr 04; 22(1). PMID: 30941236    Free PMC article.
pS6K1 as an efficacy marker of GnRH agonist with premenopausal breast cancer.
Chan Sub Park, Jihye Choi, +6 authors, Hyun-Ah Kim.
Endocr Connect, 2019 Jun 30; 8(7). PMID: 31252399    Free PMC article.
Oncologists' perspectives on adherence/non-adherence to adjuvant endocrine therapy and management strategies in women with breast cancer.
Yolanda Eraso.
Patient Prefer Adherence, 2019 Sep 20; 13. PMID: 31534318    Free PMC article.
Improving Adherence to Adjuvant Hormonal Therapy Among Disadvantaged Women Diagnosed with Breast Cancer in South Carolina: Proposal for a Multimethod Study.
Tisha M Felder, Sue P Heiney, +6 authors, Marvella E Ford.
JMIR Res Protoc, 2020 Sep 04; 9(9). PMID: 32880374    Free PMC article.
Adherence to adjuvant endocrine therapy among breast cancer survivors: a systematic review and meta-synthesis of the qualitative literature using grounded theory.
Othman AlOmeir, Nilesh Patel, Parastou Donyai.
Support Care Cancer, 2020 Jul 01; 28(11). PMID: 32601852    Free PMC article.
Systematic Review.
First prospective outcome data for the second-generation multigene test Endopredict in ER-positive/HER2-negative breast cancer.
Johannes Ettl, Sophie-Isabelle Anders, +5 authors, Marion Kiechle.
Arch Gynecol Obstet, 2020 Sep 10; 302(6). PMID: 32902674    Free PMC article.
"Nobody Will Tell You. You've Got to Ask!": An Examination of Patient-provider Communication Needs and Preferences among Black and White Women with Early-stage Breast Cancer.
Janeane N Anderson, J Carolyn Graff, +8 authors, Ilana Graetz.
Health Commun, 2020 Apr 28;. PMID: 32336140    Free PMC article.
The Patient's Voice: Adherence, Symptoms, and Distress Related to Adjuvant Endocrine Therapy After Breast Cancer.
Jamie M Jacobs, Emily A Walsh, +7 authors, Joseph A Greer.
Int J Behav Med, 2020 Jun 05; 27(6). PMID: 32495240    Free PMC article.
Nodal staging affects adjuvant treatment choices in elderly patients with clinically node-negative, estrogen receptor-positive breast cancer.
A Laws, R Cheifetz, +6 authors, E McKevitt.
Curr Oncol, 2020 Nov 12; 27(5). PMID: 33173376    Free PMC article.
Adjuvant radiation therapy alone is associated with improved overall survival compared to hormonal therapy alone in older women with estrogen receptor positive early stage breast cancer.
Sachin R Jhawar, Naomi Alpert, +8 authors, Nisha Ohri.
Cancer Med, 2020 Sep 18; 9(22). PMID: 32942344    Free PMC article.
The therapy is making me sick: how online portal communications between breast cancer patients and physicians indicate medication discontinuation.
Zhijun Yin, Morgan Harrell, +3 authors, Bradley A Malin.
J Am Med Inform Assoc, 2018 Nov 01; 25(11). PMID: 30380083    Free PMC article.
Analysis of breast cancer in young women in the Department of Defense (DOD) database.
Alexandra S Zimmer, Kangmin Zhu, +10 authors, Stanley Lipkowitz.
Breast Cancer Res Treat, 2017 Dec 17; 168(2). PMID: 29247440    Free PMC article.
A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial.
Cesar A Santa-Maria, Aditya Bardia, +15 authors, Vered Stearns.
Breast Cancer Res Treat, 2018 May 13; 171(1). PMID: 29752687    Free PMC article.
A combination of hydroxytyrosol, omega-3 fatty acids and curcumin improves pain and inflammation among early stage breast cancer patients receiving adjuvant hormonal therapy: results of a pilot study.
N Martínez, M Herrera, +5 authors, M C Crespo.
Clin Transl Oncol, 2018 Oct 08; 21(4). PMID: 30293230
Quality of life in elderly breast cancer patients with localized disease receiving endocrine treatment: a prospective study.
J I Arraras, J J Illarramendi, +9 authors, R Vera.
Clin Transl Oncol, 2019 Feb 04; 21(9). PMID: 30712234
Adherence and quality of life in women with breast cancer being treated with oral hormone therapy.
Rebeca Stahlschmidt, Amanda Canato Ferracini, +3 authors, Priscila Gava Mazzola.
Support Care Cancer, 2019 Feb 08; 27(10). PMID: 30729297
Adherence to Adjuvant Endocrine Therapy in Insured Black and White Breast Cancer Survivors: Exploring Adherence Measures in Patient Data.
Vanessa B Sheppard, Jun He, +9 authors, Mahlet G Tadesse.
J Manag Care Spec Pharm, 2019 May 01; 25(5). PMID: 31039059    Free PMC article.
Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM study.
Markus Wallwiener, Naiba Nabieva, +48 authors, Peter A Fasching.
BMC Cancer, 2019 Jun 23; 19(1). PMID: 31227025    Free PMC article.
Development of a Prognostic Tool to Guide the Decision to Extend Adjuvant Aromatase Inhibitors for up to Ten Years in Postmenopausal Early Breast Cancer Patients.
Camille Moreau-Bachelard, Loïc Campion, +6 authors, Jean-Sébastien Frénel.
Cancers (Basel), 2020 Dec 17; 12(12). PMID: 33322473    Free PMC article.
Endocrine therapy and radiotherapy use among older women with hormone receptor-positive, clinically node-negative breast cancer.
Mei Wei, Xuechen Wang, +3 authors, N Lynn Henry.
Breast Cancer Res Treat, 2021 Jan 10; 187(1). PMID: 33420863
Predictors of increased risk for early treatment non-adherence to oral anti-estrogen therapies in early-stage breast cancer patients.
Miryam Yusufov, Margo Nathan, +3 authors, Hadine Joffe.
Breast Cancer Res Treat, 2020 Sep 13; 185(1). PMID: 32918659
Impact of patients' refusal to undergo adjuvant treatment measures on survival.
H Männle, J W Siebers, F Momm, K Münstedt.
Breast Cancer Res Treat, 2020 Sep 25; 185(1). PMID: 32970241
Leveraging Mobile Sensing to Understand and Develop Intervention Strategies to Improve Medication Adherence.
Anna N Baglione, Jiaqi Gong, +2 authors, Laura E Barnes.
IEEE Pervasive Comput, 2021 Jan 30; 19(3). PMID: 33510585    Free PMC article.
Potentially Modifiable Factors Associated with Adherence to Adjuvant Endocrine Therapy among Breast Cancer Survivors: A Systematic Review.
Kirsti I Toivonen, Tamara M Williamson, +2 authors, Tavis S Campbell.
Cancers (Basel), 2021 Feb 10; 13(1). PMID: 33561076    Free PMC article.
Acupuncture for Arthralgia Induced by Aromatase Inhibitors in Patients with Breast Cancer: A Systematic Review and Meta-analysis.
Xiaomeng Liu, Jing Lu, +5 authors, Jinhai Tang.
Integr Cancer Ther, 2021 Feb 16; 20. PMID: 33586504    Free PMC article.
Simulation-Based Assessment of the Impact of Non-Adherence on Endoxifen Target Attainment in Different Tamoxifen Dosing Strategies.
Anna Mueller-Schoell, Lena Klopp-Schulze, +7 authors, Charlotte Kloft.
Pharmaceuticals (Basel), 2021 Feb 07; 14(2). PMID: 33546125    Free PMC article.
Early Discontinuation of Endocrine Therapy and Recurrence of Breast Cancer among Premenopausal Women.
Lindsay J Collin, Deirdre P Cronin-Fenton, +10 authors, Timothy L Lash.
Clin Cancer Res, 2020 Dec 19; 27(5). PMID: 33334905    Free PMC article.
The association of pharmacy fill synchronization with breast cancer endocrine therapy adherence.
Joan M Neuner, Nicole M Fergestrom, +4 authors, Liliana E Pezzin.
Cancer, 2019 Aug 03; 125(22). PMID: 31373689    Free PMC article.
Shear wave elastography detects novel imaging biomarkers of aromatase inhibitor-induced joint pain: a pilot study.
Jessica A Martinez, Mihra S Taljanovic, +6 authors, Pavani Chalasani.
J Ultrason, 2021 Apr 02; 21(84). PMID: 33791110    Free PMC article.
Similar rates of residual disease in patients with DCIS within 2 mm of lumpectomy margin regardless of the presence of invasive carcinoma.
Bridget N Kelly, Olga Kantor, +5 authors, Michelle C Specht.
Breast Cancer Res Treat, 2020 Nov 29; 186(3). PMID: 33247799
Religion and spirituality: their role in the psychosocial adjustment to breast cancer and subsequent symptom management of adjuvant endocrine therapy.
Gabriela Toledo, Carol Y Ochoa, Albert J Farias.
Support Care Cancer, 2020 Oct 10; 29(6). PMID: 33034750    Free PMC article.
Aromatase inhibitor use, side effects and discontinuation rates in gynecologic oncology patients.
Sarah G Bell, Liam Dalton, +4 authors, Karen McLean.
Gynecol Oncol, 2020 Aug 28; 159(2). PMID: 32847676    Free PMC article.
Development of health behaviour questionnaire for breast cancer women in Mainland China.
Hui Xu, Guichun Jiang, +3 authors, Aiping Wang.
Nurs Open, 2020 Dec 29;. PMID: 33369265    Free PMC article.
Racial/ethnic disparities in use of surveillance mammogram among breast cancer survivors: a systematic review.
Pragati Advani, Shailesh Advani, +5 authors, Sally W Vernon.
J Cancer Surviv, 2021 May 14;. PMID: 33982233
Development and Refinement of a Telehealth Intervention for Symptom Management, Distress, and Adherence to Adjuvant Endocrine Therapy after Breast Cancer.
Jamie M Jacobs, Emily A Walsh, +8 authors, Joseph A Greer.
J Clin Psychol Med Settings, 2020 Nov 22;. PMID: 33219901    Free PMC article.
It's not an easy fix: Adherence to adjuvant endocrine therapy after breast cancer.
Leah K Lambert, Lynda G Balneaves, A Fuchsia Howard.
Can Oncol Nurs J, 2021 May 27; 31(2). PMID: 34036161    Free PMC article.

Leah K Lambert, Lynda G Balneaves, A Fuchsia Howard.
Can Oncol Nurs J, 2021 May 27; 31(2). PMID: 34036162    Free PMC article.
Adherence to Adjuvant Tamoxifen in Mexican Young Women with Breast Cancer.
Bertha Alejandra Martinez-Cannon, Andrea Castro-Sanchez, +8 authors, Cynthia Villarreal-Garza.
Patient Prefer Adherence, 2021 May 28; 15. PMID: 34040357    Free PMC article.
Healthcare Provider Perspectives on Adherence to Adjuvant Endocrine Therapy after Breast Cancer.
Leah K Lambert, Lynda G Balneaves, +2 authors, Carolyn C Gotay.
Curr Oncol, 2021 May 01; 28(2). PMID: 33918560    Free PMC article.
The impact of medication side effects on adherence and persistence to hormone therapy in breast cancer survivors: A qualitative systematic review and thematic synthesis.
Nicola Peddie, Sommer Agnew, +3 authors, Leanne Fleming.
Breast, 2021 May 29; 58. PMID: 34049260    Free PMC article.
Sleep and endocrine therapy in breast cancer.
Kathleen Van Dyk, Hadine Joffe, Judith E Carroll.
Curr Opin Endocr Metab Res, 2021 Jun 08; 18. PMID: 34095605    Free PMC article.
The role of CDK4/6 inhibitors in early breast cancer.
Miguel Gil-Gil, Emilio Alba, +5 authors, Antonio Llombart-Cussac.
Breast, 2021 Jun 05; 58. PMID: 34087775    Free PMC article.
Adjuvant endocrine therapy for premenopausal women with breast cancer: Patient adherence and physician prescribing practices in Mexico.
Cynthia Villarreal-Garza, Fernanda Mesa-Chavez, +8 authors, Paula Cabrera-Galeana.
Breast, 2021 Jun 12; 59. PMID: 34116366    Free PMC article.
Adherence to Adjuvant Hormonal Therapy and Associated Factors Among Women with Breast Cancer Attending the Tikur Anbessa Specialized Hospital, Addis Ababa Ethiopia, 2019: A Cross-sectional Study.
Zerko Wako, Daniel Mengistu, +2 authors, Mulugeta Wassie.
Breast Cancer (Dove Med Press), 2021 Jun 18; 13. PMID: 34135629    Free PMC article.
Perceived New Normal and Inner Strength on Quality of Life in Breast Cancer Patients Receiving Adjuvant Endocrine Therapy.
Sujin Ha, Eunjung Ryu.
Asia Pac J Oncol Nurs, 2021 Jun 24; 8(4). PMID: 34159230    Free PMC article.
Breast cancer patients' insurance status and residence zip code correlate with early discontinuation of endocrine therapy: An analysis of the ECOG-ACRIN TAILORx trial.
Gelareh Sadigh, Robert J Gray, +7 authors, Ruth C Carlos.
Cancer, 2021 Apr 02; 127(14). PMID: 33793979    Free PMC article.
Perceptions of Endocrine Therapy in African-American Breast Cancer Survivors: Mixed Methods Study.
Sara Donevant, Sue P Heiney, +3 authors, Jingxi Sheng.
JMIR Form Res, 2021 Jun 12; 5(6). PMID: 34114955    Free PMC article.
Further Evidence That OPG rs2073618 Is Associated With Increased Risk of Musculoskeletal Symptoms in Patients Receiving Aromatase Inhibitors for Early Breast Cancer.
Daniel L Hertz, Karen Lisa Smith, +8 authors, Vered Stearns.
Front Genet, 2021 Jul 03; 12. PMID: 34211496    Free PMC article.
Does the Time of Day at Which Endocrine Therapy Is Taken Affect Breast Cancer Patient Outcomes?
Ana-Alicia Beltran-Bless, Lisa Vandermeer, +4 authors, Mark Clemons.
Curr Oncol, 2021 Jul 22; 28(4). PMID: 34287262    Free PMC article.
THRIVE intervention development: using participatory action research principles to guide a mHealth app-based intervention to improve oncology care.
Janeane N Anderson, Rebecca A Krukowski, +7 authors, Ilana Graetz.
J Hosp Manag Health Policy, 2021 Jul 27; 5. PMID: 34308256    Free PMC article.